|
| Status |
Public on Jul 05, 2016 |
| Title |
CellLine_8505C |
| Sample type |
genomic |
| |
|
| Source name |
8505C
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: 8505C
primary site: thyroid
primary histology: thyroid
cosmic_id: 924102
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Total DNA was isolated by standard procedures
|
| Label |
Cy3, Cy5
|
| Label protocol |
Standard Illumina labelling protocol
|
| |
|
| Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using High Scan SQ using standard recommended Illumina scanner setting
|
| Description |
Sanger cell line
|
| Data processing |
Genome Studio V2011.2
[Matrix.processed.txt] Average beta values and detection p-values. Available on the Series record.
[Matrix.Signal.Intensities.txt] Unmethylated and methylated signal intensities. Available on the Series record.
|
| |
|
| Submission date |
Apr 28, 2015 |
| Last update date |
Jul 05, 2016 |
| Contact name |
Sebastian Moran |
| Organization name |
IDIBELL
|
| Department |
PEBC
|
| Street address |
Av. Gran Via de l'Hospitalet, 199-203
|
| City |
L'Hospitalet del Llobregat |
| State/province |
Barcelona |
| ZIP/Postal code |
08908 |
| Country |
Spain |
| |
|
| Platform ID |
GPL13534 |
| Series (1) |
| GSE68379 |
The landscape of pharmacogenomic interactions in human cancer |
|
